Tarlatamab for SCLC Brain Metastases
Tarlatamab for SCLC Brain Metastases
Recruiting · NCT07402343 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tarlatamab for SCLC Brain Metastases | Neoplasms by Site, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, neoplasm, nervous system disorder, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 2 | 2026-07-31 | NCT07402343 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Erasmus Medical Center | 271 |
| Maastricht University Medical Center | 157 |
| The Netherlands Cancer Institute | 113 |
| University Medical Center Groningen | 213 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Erasmus MC | Rotterdam | Netherlands | 57 |
| Maastricht UMC+ | Maastricht | Netherlands | 22 |
| The Netherlands Cancer Institute | Amsterdam | Netherlands | 6 |
| University Medical Center Groningen | Groningen | Netherlands | 66 |